Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives … – News-Medical.net
Abbott's XIENCE Xpedition Everolimus Eluting Coronary Stent System receives …News-Medical.netAbbott (NYSE: ABT) today announced that the XIENCE Xpedition™ Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of …
